Becton Dickinson and : BD Launches First-in-Human Trial of Sirolimus Drug-Coated Balloon to Expand Treatment Options for Peripheral Arterial Disease

(marketscreener.com) First patient enrollment in PREVISION trial marks opportunity to further advance the safety and performance of drug-coated balloon technology and aligns with the company's commitment to developing innovations that enhance Chronic Disease Outcomes FRANKLIN LAKES, N.J., Aug. 18, 2022 - BD , a leading global medical technology...https://www.marketscreener.com/quote/stock/BECTON-DICKINSON-AND-COM-11801/news/Becton-Dickinson-and-BD-Launches-First-in-Human-Trial-of-Sirolimus-Drug-Coated-Balloon-to-Expand-T-41352252/?utm_medium=RSS&utm_content=20220818